| Impact of COVID-19 Disruptions on Global BCG Coverage and Paediatric TB Mortality: A Modelling Study N Shaikh, PT Pelzer, SM Thysen, P Roy, RC Harris, RG White Vaccines 9 (11), 1228, 2021 | 25 | 2021 |
| Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients SEJ van de Berg, PT Pelzer, AJ van der Land, E Abdrakhmanova, AM Ozi, ... BMC public health 21 (1), 1-13, 2021 | 20 | 2021 |
| Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021 S Suliman, PT Pelzer, M Shaku, V Rozot, SC Mendelsohn Vaccine 39 (50), 7223-7229, 2021 | 16 | 2021 |
| BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing PT Pelzer, B Mutayoba, FGJ Cobelens Journal of Infection 77 (4), 335-340, 2018 | 14 | 2018 |
| Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines PT Pelzer, J Seeley, FY Sun, M Tameris, L Tao, Z Yanlin, H Moosan, ... PLOS Global Public Health 2 (5), e0000076, 2022 | 11 | 2022 |
| Assessment of training and mentoring for DR-TB care decentralization in Tanzania D Lyakurwa, J Lyimo, C Mulder, PT Pelzer, I Koppelaar, M Heus Human resources for health 19 (1), 1-13, 2021 | 10 | 2021 |
| Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis S Jayawardana, CK Weerasuriya, PT Pelzer, J Seeley, RC Harris, ... npj Vaccines 7 (1), 1-8, 2022 | 7 | 2022 |
| Does BCG vaccination protect against infection with M. tuberculosis? PT Pelzer, Y Smit, EW Tiemersma, NT Huong, NV Nhung, F Cobelens The International Journal of Tuberculosis and Lung Disease 26 (6), 529-536, 2022 | 5 | 2022 |
| Lessons from a decade of adult vaccine rollout in low-and middle-income countries: a scoping review AK Gerste, A Majidulla, A Baidya, O Georgewill, AN DeLuca, PT Pelzer, ... Expert review of vaccines 23 (1), 688-704, 2024 | | 2024 |
| Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review JS Buis, D Jerene, A Gebhard, R Bakker, A Majidulla, AD Kerkhoff, ... PLOS Global Public Health 4 (8), e0002885, 2024 | | 2024 |
| Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report RA Clark, C Young, S Palmer, E Auma, S Malhotra, R Limaye, B Giersing, ... Frontiers in Tuberculosis 2, 1384036, 2024 | | 2024 |
| The TB vaccine clinical trial centre directory: an inventory of clinical trial centres in sub-Saharan Africa PT Pelzer, M Holleman, MEH Helinski, AL Weinberg, P Beattie, ... medRxiv, 2023.10. 04.23296539, 2023 | | 2023 |
| Does Bacillus Calmette-Guerin vaccine protect against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing? PT Pelzer, FGJ Cobelens TROPICAL MEDICINE & INTERNATIONAL HEALTH 22, 263-263, 2017 | | 2017 |
| Assessment of training and mentoring for DR-TB care decentralization in Tanzania J Lyimo, C Mulder, PT Pelzer, M Heus | | |
Richard G WhiteProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
